Insider · CIK 0001397331
Robert F Williamson III
Files at CATX (Perspective Therapeutics, Inc.). First filing Nov 27, 2024, latest Nov 14, 2025.
In brief
Robert F Williamson III files SEC Form 4 as director at CATX (Perspective Therapeutics, Inc.). Since Nov 27, 2024, Robert F Williamson III has reported 3 open-market buys worth $175k and 0 open-market sells worth $0, the latest filed on Nov 14, 2025.
A track record needs three past buys with six months of prices behind them; Robert F Williamson III has 0, so none is measured yet.
The newest scored trade: bought $20k of CATX on Nov 12, 2025, filed Nov 14, 2025, scored 41 (moderate). In the last 12 months: 1 buy worth $20k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CATX: Perspective Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Perspective Therapeutics, Inc. | $20k 9,498 shares | +2595% | +24% from low-80% from high | |
| 69Notable | Perspective Therapeutics, Inc. | $132k 60,337 shares | +124% | 0% from low-86% from high | |
| 30Weak | Perspective Therapeutics, Inc. | $23k 6,266 shares | +1% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 4, 2026 |
| Nov 12, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stockindirect: RFW3 Revocable Trust | +9,498 | $2.10 | $20k | 9,864 | Nov 14, 2025 |
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +22,192 | $2.27 | $50k | 70,837 | Apr 1, 2025 |
| Mar 31, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +38,145 | $2.14 | $82k | 108,982 | Apr 1, 2025 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +3,647 | $3.62 | $13k | 427,439 | Nov 27, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +2,619 | $3.67 | $9,612 | 430,058 | Nov 27, 2024 |
Questions about Robert F Williamson III
Answered from the filings on this page, as of the latest one.
Is Robert F Williamson III buying or selling?
In the last 12 months Robert F Williamson III reported 1 open-market buy worth $20k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20k of CATX on Nov 12, 2025. Grants, option exercises and tax withholding are not counted.
How did Robert F Williamson III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert F Williamson III has 0.
Where does Robert F Williamson III file Form 4?
Robert F Williamson III has filed Form 4 at CATX (Perspective Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.